U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 2,001 records

Showing results for "company".

  1. Disposition of Comments for Treatment To Prevent Fractures in Men and Women With Low Bone Density or Osteoporosis -- Update of a 2007 Report (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_disposition-comments.pdf
    March 01, 2012 - Introduction -KQ 1 In the Executive Summary on page ES-6 and on page 6, Amgen requests that the company … Only a single company, Merck, is singled out by name as a potential source of bias.

  2. Disposition of Comment Report for Wireless Motility Capsule Versus Other Diagnostic Technologies for Evaluating Gastroparesis and Constipation (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/wireless-motility-capsule_disposition-comments.pdf
    May 20, 2013 - Response: Saad reports in his technical review of the wireless motility capsule10 the company guidelines … This guideline was developed by the company from a review of their clinical study data and from potentially

  3. Disposition of Comments Report for CER 134 Pharmacotherapy for Adults With Alcohol-Use Disorders in Outpatient Settings (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse-drug-therapy_disposition-comments.pdf
    May 13, 2014 - is worth noting that the larger study used in the meta-analysis was sponsored by a pharmaceutical company

  4. Effectiveness of Early Diagnosis, Prevention, and Treatment of Clostridium difficile Infection (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/c-diff-infections_disposition-comments.pdf
    March 01, 2012 - delayed because there is not a funding source that is pushing from behind because the pharmaceutical company

  5. Medical-Evidence-Communication Research-Protocol (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/medical-evidence-communication_research-protocol.pdf
    July 31, 2012 - o For example, an opinion leader might be the chief executive officer of a company or the head of a

  6. Abnormal-Uterine-Bleeding Executive (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/abnormal-uterine-bleeding_executive.pdf
    March 01, 2013 - Princeton, NJ: Bristol-Myers Squibb Company; 2009. 70. Chan KA, Truman A, Gurwitz JH, et al.

  7. Patient-Centered Data Visualizations for Diabetes - Final Report (pdf file)

    digital.ahrq.gov/sites/default/files/docs/citation/r21hs023865-lee-final-report-2018.pdf
    January 01, 2018 - Signing exclusively with a single company may be less expensive overall and provide a universal platform

  8. ___APS-Def_Public.book (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/APS-Def_Public_v24.pdf
    March 01, 2008 - INGENIX The APS-DRGs® Definitions Manual is published by Ingenix, a leading healthcare information company

  9. Implementation Guide: Statin Use for the Primary Prevention of CVD in Adults: Clinician-Facing CDS Intervention (pdf file)

    cds.ahrq.gov/sites/default/files/cds/artifact/18/2024_CDS_Connect_IG_Statin_CVD_Clinician_Facing.pdf
    January 01, 2024 - The technology company uses the logic in this artifact, expanding its structured representation of the

  10. Implementation Guide: Prediabetes and Type 2 Diabetes: Part Two, Counseling (pdf file)

    cds.ahrq.gov/sites/default/files/cds/artifact/1066/2024_CDS_Connect_IG_Diabetes_Part_Two_Counseling_1.pdf
    January 01, 2024 - The technology company uses the logic in this artifact and adds additional structured representation

  11. CHIPRA 194: Overuse of Imaging for the Evaluation of Children With Primary Headache Report (pdf file)

    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-194-fullreport.pdf
    April 01, 2019 - obtained through HealthCore, Inc., an independent subsidiary of Anthem, Inc., the largest health benefits company

  12. Overuse of Computed Tomography Scans for the Evaluation of Children with a First Generalized Afebrile, Atraumatic Seizure: Report (pdf file)

    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0198-fullreport.pdf
    November 01, 2019 - obtained through HealthCore, Inc., an independent subsidiary of Anthem, Inc., the largest health benefits company

  13. Overuse of Imaging for the Evaluation of Children with Simple Febrile Seizure: Final Report (pdf file)

    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-192-fullreport.pdf
    November 01, 2019 - obtained through HealthCore, Inc., an independent subsidiary of Anthem, Inc., the largest health benefits company

  14. Putoolssect7 (doc file)

    www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/pressureulcertoolkit/putoolssect7.docx
    February 16, 2011 - This tool was adapted from a template developed by Project Agency, a British company focused on effective

  15. Final Progress Report: Emotional Influences on Diagnostic Error in Emergency Medicine: An Experimental Approach to Understand Diagnostic Failure and Facilitate Improvement for Patients with and without Mental Illness (pdf file)

    www.ahrq.gov/sites/default/files/2025-03/isbell-boudreaux-report.pdf
    January 01, 2025 - with a randomly selected sample of emergency physicians recruited by Direct Medical Data (DMD), a company

  16. 2015-05 Public (pdf file)

    hcup-us.ahrq.gov/reports/methods/2015-05_public.pdf
    January 01, 2015 - The Advisory Board Company, Cardiovascular Rounds.

  17. Final progress Report: Anticholinergics and Cognitive Decline in the Elderly with Depression (pdf file)

    www.ahrq.gov/sites/default/files/2024-01/aparasu-report.pdf
    January 01, 2024 - drug plans administered by a private third party payer, such as a pharmaceutical benefit management company

  18. Disposition of Comments for CER 172 Clostridium Difficile Diagnosis Prevention Treatment (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/c-difficile-update_disposition-comments.pdf
    March 29, 2016 - be some breakdown of how many of the studies for treatment antibiotic and non antibiotic are drug company

  19. Research White Paper Biorepositories Addendum Registries For Evaluating Patient Outcomes Third Edition (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/biorepositories-registries-guide-3rd-ed-addendum-white-paper.pdf
    February 01, 2018 - (Prepared by the Outcome DEcIDE Center [Outcome Sciences, Inc., a Quintiles company] under Contract

  20. Disposition of Comments Report for Prevention of Healthcare-Associated Infections (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/health-careassociated-infections_disposition-comments.pdf
    November 30, 2012 - Intermountain Healthcare is a very visual company the grounds, buildings, the associated decorations
SHARE:
Facebook Twitter Print Facebook Share

Similar Terms:

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

Click to show only results for the selected site.

www.ahrq.gov (516)

psnet.ahrq.gov (447)

effectivehealthcare.ahrq.gov (407)

digital.ahrq.gov (258)

www.uspreventiveservicestaskforce.org (137)

hcup-us.ahrq.gov (109)

meps.ahrq.gov (84)

integrationacademy.ahrq.gov (14)

cdsic.ahrq.gov (10)

cds.ahrq.gov (8)

pso.ahrq.gov (8)

datatools.ahrq.gov (3)